|
Sitagliptin Clinical Trials
4 actively recruiting trials across 3 locations
▲ +1 trial since June 2026
Also known as: Januvia, brand name:Jie Nuo Wei
Pipeline
Phase 1: 1Phase 2: 1Phase 3: 1
Top Sponsors
- The University of Texas Health Science Center at San Antonio1
- Peking University Third Hospital1
- Kailin Yang, MD, PhD1
- Case Comprehensive Cancer Center1
Indications
- Cancer3
- Glioblastoma2
- Grade 4 Malignant Glioma of Brain (Disorder)1
- Type 2 Diabetes (Adult Onset)1
- Polycystic Ovarian Syndrome1
Other1 trial
Iowa City, Iowa1 trial
Sitagliptin in Recurrent/Progressive Grade 4 Glioma
University of Iowa Health Care
Phase 1
Cleveland, Ohio1 trial
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute
Phase 2
San Antonio, Texas1 trial
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
University Health System Texas Diabetic Institute
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.